Article ; Online: Genomic characterization of emerging invasive Streptococcus agalactiae serotype VIII in Alberta, Canada.
2023 Volume 42, Issue 6, Page(s) 747–757
Abstract: Invasive Group B Streptococcus (GBS) can infect pregnant women, neonates, and older adults. Invasive GBS serotype VIII is infrequent in Alberta; however, cases have increased in recent years. Here, genomic analysis was used to characterize fourteen adult ...
Abstract | Invasive Group B Streptococcus (GBS) can infect pregnant women, neonates, and older adults. Invasive GBS serotype VIII is infrequent in Alberta; however, cases have increased in recent years. Here, genomic analysis was used to characterize fourteen adult invasive serotype VIII isolates from 2009 to 2021. Trends in descriptive clinical data and antimicrobial susceptibility results were evaluated for invasive serotype VIII isolates from Alberta. Isolate genomes were sequenced and subjected to molecular sequence typing, virulence and antimicrobial resistance gene identification, phylogenetic analysis, and pangenome determination. Multilocus sequencing typing identified eight ST42 (Clonal Complex; CC19), four ST1 (CC1), and two ST2 (CC1) profiles. Isolates were susceptible to penicillin, erythromycin, chloramphenicol, and clindamycin, apart from one isolate that displayed erythromycin and inducible clindamycin resistance. All isolates carried genes for peptide antibiotic resistance, three isolates for tetracycline resistance, and one for macrolide, lincosamide, and streptogramin resistance. All genomes carried targets currently being considered for protein-based vaccines (e.g., pili and/or Alpha family proteins). Overall, invasive GBS serotype VIII is emerging in Alberta, primarily due to ST42. Characterization and continued surveillance of serotype VIII will be important for outbreak prevention, informing vaccine development, and contributing to our understanding of the global epidemiology of this rare serotype. |
---|---|
MeSH term(s) | Infant, Newborn ; Humans ; Female ; Pregnancy ; Aged ; Serogroup ; Clindamycin/therapeutic use ; Streptococcus agalactiae ; Streptococcal Infections/microbiology ; Alberta/epidemiology ; Phylogeny ; Multilocus Sequence Typing ; Drug Resistance, Bacterial ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Erythromycin/therapeutic use ; Genomics ; Microbial Sensitivity Tests |
Chemical Substances | Clindamycin (3U02EL437C) ; Anti-Bacterial Agents ; Erythromycin (63937KV33D) |
Language | English |
Publishing date | 2023-04-21 |
Publishing country | Germany |
Document type | Journal Article |
ZDB-ID | 603155-9 |
ISSN | 1435-4373 ; 0934-9723 ; 0722-2211 |
ISSN (online) | 1435-4373 |
ISSN | 0934-9723 ; 0722-2211 |
DOI | 10.1007/s10096-023-04606-9 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1732: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.